•  
  •  
  •  
  •  

2025-09-29 22:11:08

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark

Keywords Selected:  SuvenPharmaceuticals

Stock Report

  • Suven Pharmaceuticals Ltd is now Cohance Lifesciences Ltd
  • Suven Pharmaceuticals announces May 1, 2025 as Effective Date for Amalgamation of Cohance Lifesciences
  • Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
  • Suven to acquire controlling stake in NJ Bio, Inc., an ADC specialist player
  • Suven Pharmaceuticals names Mr. Vivek Sharma as Executive Chairman
  • Suven Pharmaceuticals Ltd gets Form 483 from USFDA for inspection at Casper Pharma Pvt Ltd
  • Suven to acquire a majority stake in an oligonucleotide focused CDMO player, Sapala Organics
  • Suven announces merger of Cohance Lifesciences
  • Suven Pharmaceuticals Ltd's API and Forumulations facilities complete USFDA inspection successfully
  • Advent International announces the completion of the acquisition of Suven Pharma
  • Berhyanda Ltd gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals Ltd
  • Suven Pharmaceuticals Ltd consolidated Q1FY24 PAT at Rs. 120.58 crores
  • Suven Pharmaceuticals Ltd posts rise in Q4FY23 consolidated PAT to Rs. 123.97 crores
  • Suven Pharmaceuticals Ltd reports consolidated PAT of Rs. 107.72 crores in Q3FY23
  • Advent announces Open offer for Suven Pharma at Rs. 495 per share
  • Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family
  • Suven Pharmaceuticals Ltd reports consolidated PAT of Rs. 72.05 crores in Q2FY23
  • Casper Pharma Receives EIR from USFDA for its PAI
  • Suven Pharmaceuticals declares interim dividend of Rs. 1, special dividend of Rs. 5
  • Suven Pharmaceuticals Ltd Q1FY23 consolidated profit higher at Rs. 107.54 crores
  • Casper Pharma completed USFDA pre-approval inspection
  • Suven Pharmaceuticals Q4 FY2022 consolidated PAT slides QoQ to Rs. 91.66 crores
  • Suven Pharmaceuticals Limited declares 2nd interim dividend of Rs. 1
  • Suven Pharmaceuticals approves acquisition of Casper Pharma Pvt Ltd

Latest Post

  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024